ATNM vs ABVC
Comparison between Actinium Pharmaceuticals Inc (ATNM, Company) and ABVC BioPharma Inc (ABVC, Company).
Both ATNM and ABVC are from the Healthcare sector.
5-Year PerformanceATNM has outperformed ABVC, delivering a return of -34.2% compared to -53.0%
ATNM vs ABVC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ATNM vs ABVC - Historical Returns
Returns include dividend reinvestment.
ATNM vs ABVC - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | ATNM | ABVC |
|---|---|---|
| 2026 | -38.89% | -53.88% |
| 2025 | +7.94% | +232.14% |
| 2024 | -76.32% | -50.83% |
| 2023 | -49.30% | -80.67% |
| 2022 | +66.41% | -81.34% |
| 2021 | -23.54% | -32.87% |
| 2020 | +9.24% | +1.49% |
| 2019 | -50.03% | -88.44% |
| 2018 | -40.09% | +0.00% |
| 2017 | -27.03% | +0.00% |
| 2016 | -74.26% | -74.88% |
| 2015 | -44.88% | +249920.85% |
| 2014 | -13.00% | +0.00% |
| 2013 | +292.67% | +88.68% |
| 2012 | +0.00% | -94.11% |
| 2011 | N/A | -43.75% |
ATNM vs ABVC Drawdown Comparison
The maximum drawdown for ATNM was -99.79%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The maximum drawdown for ABVC was -99.97%, occurring on Feb 13, 2025. This drawdown has not yet recovered.
The current ATNM drawdown is -99.79%. The current ABVC drawdown is -99.94%.
| Rank | ATNM | ABVC |
|---|---|---|
| #1 | -99.79% Apr 23, 2014 - Jul 29, 2026 | -99.97% Aug 24, 2015 - Feb 13, 2025 |
| #2 | -58.67% Mar 20, 2013 - Dec 10, 2013 | -99.80% Aug 26, 2011 - Aug 24, 2015 |
| #3 | -32.13% Dec 10, 2013 - Mar 12, 2014 | -89.75% Apr 21, 2011 - Aug 10, 2011 |
| #4 | -11.51% Mar 25, 2014 - Mar 31, 2014 | -62.50% Aug 17, 2011 - Aug 26, 2011 |
| #5 | -10.70% Apr 3, 2014 - Apr 23, 2014 | N/A |
| #6 | -4.17% Mar 14, 2014 - Mar 25, 2014 | N/A |
| #7 | -0.40% Mar 31, 2014 - Apr 2, 2014 | N/A |
Correlation
Correlation between ATNM and ABVC is -0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks